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THE proliferation of malignant cells has been shown to depend not only on
intrinsic neoplastic properties but also on environmental circumstances, in vivo
(host) or in vitro (medium). In addition, a changing rate ofgrowth in a continuing
environment has been documented in tumor-bearing hosts and tissue culture
situations. The kinetics ofneoplastic cells (i.e. Ehrlich ascites tumor cells-EAT)
have been studied with regard to cellular proliferation within cell-tight millipore
chambers by Amos and Wakefield (1958) (among others), particularly concerning
the growth rate of cells in normal mice and the rate of entry of iso-antibody into
the chambers. The present investigations define the growth pattern of Ehrlich
ascites tumor cells within the restricted environment of millipore chambers in
actively immunized mice.
MATERIALS AND METHODS
White Swiss mice of both sexes (HA/ICR strain), 3-4 months old, were used
in this study. The tumor cells used were Lettre strain, hyperdiploid Ehrlich
ascites tumor originally obtained from Roswell Park Memorial Institute and grown
locally through passage in HA/ICR mice. Millipore chambers, 14 mm. x 2 mm.,
were used. The rings were No. PROO01401, with filling holes, and the filters used
were No. HAWPO1400, with a porosity of 0 45 microns. The chambers were
assembled using MF cement No. 1. Fresh peritoneal fluid from an 8-day tumor-
bearing mouse was harvested and cell counts obtained. A sterile preparation of
ten million cells per cu. ml. in normal saline was then prepared. One-tenth ml.
of this suspension (one million cells) was then injected into the chamber and the
hole plugged by special nylon thread. The chambers were then implanted
intraperitoneally in the designated mice.
Mice were anesthetized using 10% Dibutal in doses of 025 ml. to 0 4 ml. A
depilatory agent (Nair) was used to remove hair, and a 1-inch incision was made
using sterile precautions in the lower right quadrant ofthe abdomen for placement
of the chamber intraperitoneally. The wound was closed with two 9 mm. metal
clips and Neomycin powder applied. The metal clips were removed from the
mice 2 days post-operatively.
At specific times, the chambers were withdrawn and thoroughly washed in
saline to remove all tissue, cells, and debris on the outside. The filters were then
freed from the ring, and all parts were dropped into a 50 ml. sterile tube containing
2 ml. of normal saline. The tube and the contents were vigorously agitated on a
Vortex junior mixer for 5 minutes to break up tumor clumps and suspend all cells
equally in the saline. The suspension was filtered through a small piece of glass
wool to remove filter particles. Cell counts were performed on this suspensionEHRLICH ASCITES TUMOR GROWTH
using a hemocytometer and the total number of cells contained in the chamber
calculated.
Antigen for immunization was obtained from the peritoneal cavity of tumor-
bearing mice. Peritoneal fluid was centrifuged in a graduated tube to note packed
cell volume. The supernatant was discarded and the cells resuspended in an
equal volume of 0.85oo saline. This suspension was then dispersed in 2 ml.
aliquots for lyophilization and storage (each tube then contained the dried consti-
tuents of 1 ml. of tumor cells). Before injection, 1 ml. of 0.85% saline and I ml.
of Freund's complete adjuvant were added to this dried powder and the compo-
nents thoroughly mixed for 10 minutes on a Vortex junior mixer. The following
schedule for injectons was used:
Day 1-0-25 ml. antigen intramuscularly (i.m.) (rear legs)
Day 8-0 30 ml. antigen intraperitoneally (i.p.)
Day 15-0 30 ml. antigen i.p.
Day 22-0 30 ml. antigen i.p.
Day 29 0 30 ml. antigen i.p.
The weight of 1 ml. of dry tumor cells was 36 mg. Therefore, 36 mg. of cell
fragments was dissolved in 1 ml. of normal saline and 1 ml. of Freund's adjuvant
(giving approximately 26 mg. of cell fragments per mouse over the 5-week
immunization period).
RESU'LTS
1. EAT growth curve in chambers in normal mice (Fig. 1)
Forty-one mice were used in deriving this normal growth curve. Readings
were taken at 2-day intervals using at least 2 mice for each determination. When
changes in rate were taking place rapidly, larger numbers of mice were used in
determining cell counts of chambers to ensure accuracy. The growth " curve "
represents a smooth curve drawn between points representing average cell counts
found at specified times.
Tumor cell growth was first characterized by an exponential increase in the
number of cells, with little if any initial lag in this system. Beginning with
1 x 106 cells per chamber, there was an increase to 6 x 106 cells. This initial
phase was followed by a period in which the total cell counts per chamber
approached an asymptote with approximately 8-5 x 106 cells per chamber.
2. EAT growth rate in chambers in immune mice (Fig. 1)
Growth rate curves in immune mice were determined in the same manner as in
normal mice, beginning with 1 x 106 cells in the chambers and sampling at 2-day
intervals. In Fig. 1, it can be seen that there was similar proliferation up to the
fourth day. After this time, varying amounts of cell destruction were observed.
This 4-day period ofsimilar growth may represent the time needed for equilibration
of humoral cytotoxic substances between the peritoneal fluid and the chamber.
It appears that the longer the mouse had been immune before receiving the
chamber with EAT, the greater the amount of cell destruction seen after the 4-day
period. The EAT cells were not completely eliminated by the immune mice
within the chambers at any of the time intervals. Table I is a composite chart
showing the average normal count plus an average ofthe counts determined in the
immune mice related to the interval after immunization.
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FIG. 1. Ehrlich ascites tumor (EAT) growth in millipore chambers in normal and immunized
mice. The heavy dark line is the growth rate curve ofEAT in millipore chambers in normal
mice. The light straight lines (* 0*) show an " average " of cell counts of EAT in
chambers in immune mice. The numbers underneath the lines indicate the number of mice
sacrificed for chamber count on a specific day. The three groups of immune mice (* * *)
vary in the interval post-immunization prior to implantation of chambers, as detailed in
Table 2. (* 7 days, *-21 days, 0-180 days.)
TABLE I.-The Relationship Between the Interval After Immunization and the
Average Number of EAT Cells in the Millipore Chamber (see Fig. 1)
Number of days
Number post-immunization
Experiment of before implantation
symbol mice ofEAT in chambers
Average of the
total number
of all counts
of EAT cells
in the chambers
after 4 days
implantation
*--
41
20
17
13
Not immunized,
normal control
7 days
21 days
180 days
3. The growth ofEAT intraperitoneally in normal and immune mice
To correlate the " chamber " studies and the normal processes of EAT growth
in normal mice and mice immunized by the present method, two groups of animals
were employed. Twenty-three normal mice (11 female, 12 male) and 28 immune
mice (14 female, 14 male) were injected with 1 x 106 EAT 21 days after the
immunization procedure was completed.
The death of these mice after intraperitoneal EAT injection is recorded in
Table II. It is apparent that the normal mice died at 21 ± 2 days, whereas
5-1 x 106
2-42 x 106
1-91 x 106
1-36 x 106
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TABLE II.-Death After EAT Intraperitoneally (Days)
AMice Number 1-19 20-22 23-30 30-40 40-60 60-90 90+
Normal 23 . 0 18 3 1 1 0 0
Immtune 28 0 2 1 0 5 1 . 17
immunized mice receiving the same dose of EAT had a definitely prolonged
longevity. It is also apparent from these two groups of mice, as well as the
chamber studies, that there is individual variation in the response from mouse to
mouse. It was noted that approximately 1 in 15 mice showed an apparent natural
resistance to EAT; after prolonged retention and observation, these mice even-
tually died of the tumor between 40 and 60 days. In the immunized group, a
similar ratio of mice was noted which did not develop an immunity to EAT and
died at the same time as normal mice treated similarly.
4. Control studies on cell counting evaluation
To check for cell loss during the counting procedure outlined above, the ring
and filters were resuspended in 2 ml. ofsaline and thoroughly agitated. Additional
cell counts were done on the supernatant. The glass wool filter was treated by
vigorous agitation. suspended in saline, and cell counts done on this supernatant
also. These controls produced negligible cell counts, thereby indicating that the
methods used accounted for approximately 9700 of the cells. Therefore, few cells
(approximately 30 ) had remained attached to the ring or the filters themselves,
and few were lost in the glass wool filter. Cell clumps were encountered rarely in
the chamber fluid, thereby enabling the use of the glass wool filter without gross
cell loss.
To check for possible migration of cells through the filters, 6 normal mice
received empty chambers intraperitoneally. Four days later, these mice were
inoculated with 0-2 ml. ofundiluted fresh tumor fluid. At 10-14 days, when these
mice were grossly distended with EAT, they were killed and the chambers
examined. These chambers were filled with peritoneal fluid, but there were no
cells (EAT, or normal WBC's) seen microscopically, indicating no, or at least very
minimal, passage of EAT through the filters from an area ofmassive tumor concen-
tration in the peritoneal cavity to the inside of the chamber. Animals followed
for 60-90 days after EAT-chamber placement did not develop the tumor, even
when the chambers remained intraperitoneally, indicating no, or minimal, migra-
tion from within a chamber out into the peritoneal cavity.
DISCUSSION
The method of study used here necessarily influences the growth of intra-
peritoneal EAT by circumstances non-operative in the absence of millipore
chambers. This investigation was specifically aimed at the evaluation of EAT
proliferation inside millipore chambers, a circumstance combining an in vivo
environment with an in vitro accounting of total cells. The derived growth
curves show exponential growth of EAT essentially without a lag phase, followed
by a leveling period. Capalbo, Albright and Bennett (1964) have shown that
small numbers of white blood cells can apparently pass through chambers with a
0.45 ,u pore size. The passage of EAT cells did not appear to be a factor in this
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study, since reverse passage into empty chambers could not be documented, nor
did mice with EAT in chambers develop tumors on prolonged follow-up.
Quantitative approaches to ascites tumor growth in mice previously reported
include those of Patt and Blackford (1954), Klein and Revesz (1953), and Baserga
(1963). Many of these studies deal with the estimation of the number of free
tumor cells in the peritoneal cavity. The growth curves described resemble those
obtained in the present study, with exponential growth followed by a leveling
phase. EAT cells in tissue culture also show a similar phasic proliferation.
The growth of EAT in passively immunized mice has been investigated by
several groups, including Lindner (1958, 1960) and Levi et al. (1959), and such
studies demonstrate immune inhibition (Amos and Wakefield, 1958). Also,
Harveit (1963, 1962), who has done considerable work with the mouse-EAT
system, has shown a.cytotoxic factor in the ascitic fluid and has also demonstrated
production of active immunization to EAT in mice. However, quantitative
studies in actively immunized mice have been largely bypassed, perhaps due to
the heterogeneity of the immune response in a group of mice.
The growth of EAT within millipore chambers in actively immunized mice
demonstrates inhibition of EAT growth. The EAT cells were not completely
destroyed however, but apparently survived at a reduced rate ofgrowth. In those
animals that were immunized and later challenged by EAT, immunity was signifi-
cant but not complete. Variation was noted in fact, regarding tumor challenge in
both the normal and immunized mice.
The nature ofthis mechanism has not been identified by this study. Considera-
tions include the possible transfer of: (a) classic antibody with or without comple-
ment, (b) the immune lymphocyte factor of Lawrence et al. (1963), (c) immune
lymphocyte RNA (Mannick and Egdahl, 1964), (d) other factors to affect EAT cells
either directly or in conjunction with trapped leukocytes, and (e) mononuclear
cells, though probably in insufficient quantity in this study to achieve the result
appreciated by themselves.
SUMMARY
This investigation documents the quantitative growth of EAT cells in normal
and actively immunized mice, using an in vivo millipore chamber technique. The
presence of an inhibitor of EAT cell growth was demonstrated in actively immun-
ized mice.
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